Evidence map›Paper›PMID 21295962›Full record

ReviewThe Journal of nutritional biochemistry2011

Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds.

Yanyan Li, Max S Wicha, Steven J Schwartz, Duxin Sun

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in The Journal of nutritional biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03167268 (Double-blind, Phase II Study to Assess the Effectiveness of Lycopene vs Placebo to Reduce Skin Toxicity in Patients With Colorectal Carcinoma Treated With Panitumumab), which is not on this map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03167268 phase2unknown statusnot on this mapstarted 2016, after this paper: background citation

Double-blind, Phase II Study to Assess the Effectiveness of Lycopene vs Placebo to Reduce Skin Toxicity in Patients With Colorectal Carcinoma Treated With Panitumumab

TypeinterventionalSponsorOspedale San Carlo BorromeoRan2016 to 2021Enrolled28ConditionsColorectal Cancer Metastatic, Skin ToxicityArmsLycopene, Placebo
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. SF1, a Standardised Fraction fromThe Malaysian journal of medical sciences : MJMS · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Pancreatic cancer stemness: dynamic status in malignant progression.Journal of experimental & clinical cancer research : CR · 2023
    Review
  10. Review
  11. Review
  12. Article
  13. Stem Cell Models for Cancer Therapy.International journal of molecular sciences · 2022
    Review
  14. Potential of Anti-inflammatory Molecules in the Chemoprevention of Breast Cancer.Recent advances in inflammation & allergy drug discovery · 2022
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yanyan LiDepartment of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA.
Max S Wicha
Steven J Schwartz
Duxin Sun
The Ohio State University · USUniversity of Michigan–Ann Arbor · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Stem Cell Self-Renewal mammary CarcinogenesisR01CA129765 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WICHA, MAX S. · 2008 to 2015
$2.4M
An integrated system for tumor detection and targeted drug therapy of cancerR01CA120023 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SUN, DUXIN · 2007 to 2011
$1.4M
New molecular target and its inhibitors for use against pancreatic cancerR21CA143474 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SUN, DUXIN · 2010 to 2011
$353k
NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA120023NCI NIH HHS R01 CA129765NCI NIH HHS R21 CA143474
6 · The paper itself

Abstract

The emergence of cancer stem cell theory has profound implications for cancer chemoprevention and therapy. Cancer stem cells give rise to the tumor bulk through continuous self-renewal and differentiation. Understanding the mechanisms that regulate self-renewal is of greatest importance for discovery of anticancer drugs targeting cancer stem cells. Naturally occurring dietary compounds have received increasing attention in cancer chemoprevention. The anticancer effects of many dietary components have been reported for both in vitro and in vivo studies. Recently, a number of studies have found that several dietary compounds can directly or indirectly affect cancer stem cell self-renewal pathways. Herein we review the current knowledge of most common natural dietary compounds for their impact on self-renewal pathways and potential effect against cancer stem cells. Three pathways (Wnt/β-catenin, Hedgehog and Notch) are summarized for their functions in self-renewal of cancer stem cells. The dietary compounds, including curcumin, sulforaphane, soy isoflavone, epigallocatechin-3-gallate, resveratrol, lycopene, piperine and vitamin D(3), are discussed for their direct or indirect effect on these self-renewal pathways. Curcumin and piperine have been demonstrated to target breast cancer stem cells. Sulforaphane has been reported to inhibit pancreatic tumor-initiating cells and breast cancer stem cells. These studies provide a basis for preclinical and clinical evaluation of dietary compounds for chemoprevention of cancer stem cells. This may enable us to discover more preventive strategies for cancer management by reducing cancer resistance and recurrence and improving patient survival.

Indexed as

DietAlkaloidsAnimalsAnticarcinogenic AgentsBenzodioxolesbeta CateninCarotenoidsCatechinCell DifferentiationCell ProliferationCholecalciferolCurcuminHumansIsoflavonesIsothiocyanatesLycopeneAlkaloidsAnticarcinogenic AgentsBenzodioxolesbeta CateninCarotenoidsCatechinCholecalciferolCurcuminepigallocatechin gallateIsoflavonesIsothiocyanatesLycopenePiperidinespiperinePolyunsaturated AlkamidesResveratrolStilbenessulforaphaneSulfoxidesThiocyanatesWnt Proteins

Identifiers

PMID21295962
PMCPMC3248810
OpenAlexW2124254475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.